Skip to main content
David Moliterno, MD, Cardiology, Lexington, KY, Lexington VAMC

DavidJonMoliternoMD

Cardiology Lexington, KY

Interventional Cardiology

Professor of Internal Medicine

Dr. Moliterno is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Moliterno's full profile

Already have an account?

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 1993 - 1994
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Cardiovascular Disease, 1990 - 1993
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Internal Medicine, 1987 - 1990
  • Virginia Commonwealth University School of Medicine
    Virginia Commonwealth University School of MedicineClass of 1987

Certifications & Licensure

  • KY State Medical License
    KY State Medical License 2004 - 2025
  • OH State Medical License
    OH State Medical License 1993 - 2012
  • TN State Medical License
    TN State Medical License 1988 - 1994
  • TX State Medical License
    TX State Medical License 1991 - 1994
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
  • Whos Who in Medicine and Healthcare Marquis Whos Who
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary Interventions  
    David J Moliterno, Susan S Smyth, Ahmed Abdel-Latif, JAMA
  • Effects of Genetic Variation in Protease Activated Receptor 4 After an Acute Coronary Syndrome: Analysis from the TRACER Trial  
    Paolo Fortina, David J Moliterno, Robert A Harrington, Kenneth W Mahaffey, ScienceDirect

Lectures

  • Best of JACC: Interventions 2018 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Best of JACC Journals and Eugene Braunwald Keynote 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Year in Review Speaker 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Authored Content

  • CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary InterventionsAugust 2020

Press Mentions

  • Immediate Complete Revascularization Is Helpful in ACS
    Immediate Complete Revascularization Is Helpful in ACSMarch 6th, 2023
  • No Downside to Immediate Complete Revascularization in ACS: BIOVASC
    No Downside to Immediate Complete Revascularization in ACS: BIOVASCMarch 6th, 2023
  • Immediate Complete Revascularization Non-Inferior to Staged Procedure
    Immediate Complete Revascularization Non-Inferior to Staged ProcedureMarch 5th, 2023
  • Join now to see all

Professional Memberships

Hospital Affiliations